ENDRA Life Sciences's total assets for Q3 2025 were $1.96M, a decrease of -30.04% from the previous quarter. NDRA total liabilities were $1.79M for the fiscal quarter, a 34.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.